Variants of DNA mismatch repair genes derived from 33,998 Chinese individuals with and without cancer reveal their highly ethnic-specific nature-Reference-Cited by-同舟云学术

Variants of DNA mismatch repair genes derived from 33,998 Chinese individuals with and without cancer reveal their highly ethnic-specific nature

Published:2020-01 Issue: Volume:125 Page:12-21
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Zhang Li,Bhaskaran Shanmuga Priya,Huang Teng,Dong Hui,Chandratre Khyati^ORCID,Wu Xiaobing,Qin Zixin,Wang Xiaoyu,Cao Wenming,Chen Tianhui,Lynch Henry,Wang San Ming^ORCID

Funder

Macau Science and Technology Development Fund

University of Macau

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Cancer risk associated with germline DNA mismatch repair gene mutations;Dunlop;Hum Mol Genet,1997

2. Milestones of Lynch syndrome: 1895-2015;Lynch;Nat Rev Cancer,2015

3. PD-1 blockade in tumors with mismatch-repair deficiency;Le;N Engl J Med,2015

4. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer;Fishel;Cell,1993

5. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer;Bronner;Nature,1994

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes;Human Genomics;2024-01-29

2. Rare single‐nucleotide variants of MLH1 and MSH2 genes in patients with Lynch syndrome;Cancer Reports;2023-11-02

3. Dos eventos genéticos sobresalientes en carcinoma oral de células escamosas: Variante c.-93 G>A y metilación del promotor de MLH1;TECNOCIENCIA Chihuahua;2023-08-29

4. Prevalence and genetic spectrum associated with hereditary colorectal cancer syndromes, the need to improve cancer risk awareness, and family cascade testing in Vietnam;Familial Cancer;2023-07-30

5. Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patients;Cancer Immunology, Immunotherapy;2022-12-16